Want to create an interactive transcript for this episode?
Podcast: Relentless Health Value
Episode: EP278: COVID-19—Will COVID-19 Result in a New Normal for Value-based Pharmaceutical Pricing? With Maura Calsyn From the Center for American Progress
Description: In this health care podcast, I'm speaking with Maura Calsyn from the Center for American Progress—or CAP—and we're talking about value-based drug pricing and the impact that COVID-19 may have on its definition, operationalism, and broad adoption. I remember a situation (kind of years ago, actually) where a pharma company decided to lower its price on an infused product. Normal supply and demand would dictate that if you lower your price, you will get more overall business, which will result potentially in more overall revenue—the old supply-and-demand curve at work. In this case, though, that p...